Publication | Closed Access

Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome

ObesityMetabolic SyndromeC-reactive ProteinMetabolic DisorderCardiovascular DiseaseMedicineMicrovascular DysfunctionDiabetesPhysiologyMetabolic ComplicationVascular BiologyEndothelial FunctionMetabolismPharmacologyAtherosclerosisDyslipidemiaOxidative StressHealth Sciences